As of 2025-07-17, the Intrinsic Value of Andon Health Co Ltd (002432.SZ) is 20.39 CNY. This 002432.SZ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 38.60 CNY, the upside of Andon Health Co Ltd is -47.20%.
The range of the Intrinsic Value is 15.78 - 29.13 CNY
Based on its market price of 38.60 CNY and our intrinsic valuation, Andon Health Co Ltd (002432.SZ) is overvalued by 47.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 15.78 - 29.13 | 20.39 | -47.2% |
| DCF (Growth 10y) | 21.02 - 37.46 | 26.76 | -30.7% |
| DCF (EBITDA 5y) | 53.84 - 111.67 | 84.51 | 118.9% |
| DCF (EBITDA 10y) | 54.27 - 119.52 | 86.57 | 124.3% |
| Fair Value | 89.22 - 89.22 | 89.22 | 131.13% |
| P/E | 101.67 - 204.91 | 149.91 | 288.4% |
| EV/EBITDA | 20.47 - 40.34 | 29.35 | -24.0% |
| EPV | 87.27 - 112.91 | 100.09 | 159.3% |
| DDM - Stable | 20.93 - 49.67 | 35.30 | -8.6% |
| DDM - Multi | 43.95 - 82.36 | 57.45 | 48.8% |
| Market Cap (mil) | 18,253.56 |
| Beta | 0.98 |
| Outstanding shares (mil) | 472.89 |
| Enterprise Value (mil) | 18,768.16 |
| Market risk premium | 6.13% |
| Cost of Equity | 12.70% |
| Cost of Debt | 5.00% |
| WACC | 11.37% |